New HCRC Study Analyzes Marketing Strategies Of Successful Drug Launches; Research Helps Investors, Analysts Better Forecast Revenue From New Drugs

HealthCare Research and Consulting (HCRC) Corporation, a leading independent research and advisory firm specializing in the pharmaceutical and healthcare industries, today announced the launch of HCRC Quarterly, a research report that analyzes the marketing strategies behind drug launches to enable industry financial analysts and investors to more accurately assess the potential of newly launched products.